Imprimis Pharmaceuticals, Inc. (IMMY)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.30+0.05 (+2.22%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close2.25
Bid0.00 x 0
Ask0.00 x 0
Day's Range2.15 - 2.33
52 Week Range1.65 - 4.69
Avg. Volume199,814
Market Cap46.15M
PE Ratio (TTM)-1.75
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press10 days ago

    Imprimis posts 2Q profit

    On a per-share basis, the San Diego-based company said it had net income of 6 cents. The pharmaceutical and drug compounding company posted revenue of $6.9 million in the period. In the final minutes of ...

  • Forbes16 days ago

    FDA Links Naturopathic Turmeric Death To Contaminated Product

    A curcumin emulsion for injection made by compounding pharmacy ImprimisRx contained a dangerous impurity. The company formulates a variety of questionable products for intravenous use and pays a popular naturopathic doctor as a consultant.

  • Capital Cube2 months ago

    ETFs with exposure to Imprimis Pharmaceuticals, Inc. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Imprimis Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IMMY-US. Comparing the performance and risk of Imprimis Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)